 | • レポートコード：MRC2-11QY11012 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は細菌性肺炎治療薬のグローバル市場について調査・分析したレポートです。種類別（抗生物質、ワクチン）市場規模、用途別（病院薬局、小売薬局、通信販売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別細菌性肺炎治療薬の競争状況、市場シェア ・世界の細菌性肺炎治療薬市場：種類別市場規模 2015年-2020年（抗生物質、ワクチン） ・世界の細菌性肺炎治療薬市場：種類別市場規模予測 2021年-2026年（抗生物質、ワクチン） ・世界の細菌性肺炎治療薬市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、通信販売薬局） ・世界の細菌性肺炎治療薬市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、通信販売薬局） ・北米の細菌性肺炎治療薬市場分析：米国、カナダ ・ヨーロッパの細菌性肺炎治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの細菌性肺炎治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の細菌性肺炎治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの細菌性肺炎治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AstraZeneca、Nabriva Therapeutics、SetLance、Merck、Daiichi Sankyo Company、GlaxoSmithKline、Pfizer、Sanofi Pasteur ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affects over 450 million people across the globe and results in four million deaths every year.
Increase in bacterial resistance of streptococcus bacteria, HIV associated pneumonia, rise in prevalence of pneumonia and government initiatives are major factors driving the growth of bacterial pneumonia therapeutics market over the forecast period. According to national statistics UK, in 2013, 5% of deaths in England and Wales are associated due to pneumonia and influenza. Lack of new drugs and improper diagnosis of pneumonia conditions are hindering the growth of this market over the forecast period.
Market Analysis and Insights: Global Bacterial Pneumonia Therapeutics Market
The global Bacterial Pneumonia Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Bacterial Pneumonia Therapeutics Scope and Market Size
Bacterial Pneumonia Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bacterial Pneumonia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
AstraZeneca
Nabriva Therapeutics
SetLance
Merck
Daiichi Sankyo Company
GlaxoSmithKline
Pfizer
Sanofi Pasteur
Market segment by Type, the product can be split into
Antibiotics
Vaccines
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Mail Order Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bacterial Pneumonia Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Bacterial Pneumonia Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antibiotics
1.4.3 Vaccines
1.5 Market by Application
1.5.1 Global Bacterial Pneumonia Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Mail Order Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Bacterial Pneumonia Therapeutics Market Perspective (2015-2026)
2.2 Global Bacterial Pneumonia Therapeutics Growth Trends by Regions
2.2.1 Bacterial Pneumonia Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bacterial Pneumonia Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Bacterial Pneumonia Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Bacterial Pneumonia Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Bacterial Pneumonia Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Bacterial Pneumonia Therapeutics Players by Market Size
3.1.1 Global Top Bacterial Pneumonia Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Bacterial Pneumonia Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Bacterial Pneumonia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bacterial Pneumonia Therapeutics Market Concentration Ratio
3.2.1 Global Bacterial Pneumonia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Bacterial Pneumonia Therapeutics Revenue in 2019
3.3 Bacterial Pneumonia Therapeutics Key Players Head office and Area Served
3.4 Key Players Bacterial Pneumonia Therapeutics Product Solution and Service
3.5 Date of Enter into Bacterial Pneumonia Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bacterial Pneumonia Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Bacterial Pneumonia Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020)
5.2 Global Bacterial Pneumonia Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Bacterial Pneumonia Therapeutics Market Size (2015-2020)
6.2 Bacterial Pneumonia Therapeutics Key Players in North America (2019-2020)
6.3 North America Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020)
6.4 North America Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Bacterial Pneumonia Therapeutics Market Size (2015-2020)
7.2 Bacterial Pneumonia Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020)
7.4 Europe Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Bacterial Pneumonia Therapeutics Market Size (2015-2020)
8.2 Bacterial Pneumonia Therapeutics Key Players in China (2019-2020)
8.3 China Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020)
8.4 China Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Bacterial Pneumonia Therapeutics Market Size (2015-2020)
9.2 Bacterial Pneumonia Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020)
9.4 Japan Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Bacterial Pneumonia Therapeutics Market Size (2015-2020)
10.2 Bacterial Pneumonia Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Bacterial Pneumonia Therapeutics Market Size (2015-2020)
11.2 Bacterial Pneumonia Therapeutics Key Players in India (2019-2020)
11.3 India Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020)
11.4 India Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Bacterial Pneumonia Therapeutics Market Size (2015-2020)
12.2 Bacterial Pneumonia Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AstraZeneca
13.1.1 AstraZeneca Company Details
13.1.2 AstraZeneca Business Overview
13.1.3 AstraZeneca Bacterial Pneumonia Therapeutics Introduction
13.1.4 AstraZeneca Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020))
13.1.5 AstraZeneca Recent Development
13.2 Nabriva Therapeutics
13.2.1 Nabriva Therapeutics Company Details
13.2.2 Nabriva Therapeutics Business Overview
13.2.3 Nabriva Therapeutics Bacterial Pneumonia Therapeutics Introduction
13.2.4 Nabriva Therapeutics Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020)
13.2.5 Nabriva Therapeutics Recent Development
13.3 SetLance
13.3.1 SetLance Company Details
13.3.2 SetLance Business Overview
13.3.3 SetLance Bacterial Pneumonia Therapeutics Introduction
13.3.4 SetLance Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020)
13.3.5 SetLance Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Bacterial Pneumonia Therapeutics Introduction
13.4.4 Merck Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Daiichi Sankyo Company
13.5.1 Daiichi Sankyo Company Company Details
13.5.2 Daiichi Sankyo Company Business Overview
13.5.3 Daiichi Sankyo Company Bacterial Pneumonia Therapeutics Introduction
13.5.4 Daiichi Sankyo Company Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020)
13.5.5 Daiichi Sankyo Company Recent Development
13.6 GlaxoSmithKline
13.6.1 GlaxoSmithKline Company Details
13.6.2 GlaxoSmithKline Business Overview
13.6.3 GlaxoSmithKline Bacterial Pneumonia Therapeutics Introduction
13.6.4 GlaxoSmithKline Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020)
13.6.5 GlaxoSmithKline Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Bacterial Pneumonia Therapeutics Introduction
13.7.4 Pfizer Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Sanofi Pasteur
13.8.1 Sanofi Pasteur Company Details
13.8.2 Sanofi Pasteur Business Overview
13.8.3 Sanofi Pasteur Bacterial Pneumonia Therapeutics Introduction
13.8.4 Sanofi Pasteur Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020)
13.8.5 Sanofi Pasteur Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Bacterial Pneumonia Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Bacterial Pneumonia Therapeutics Revenue
Table 3. Ranking of Global Top Bacterial Pneumonia Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Bacterial Pneumonia Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Antibiotics
Table 6. Key Players of Vaccines
Table 7. Global Bacterial Pneumonia Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Bacterial Pneumonia Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Bacterial Pneumonia Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Bacterial Pneumonia Therapeutics Market Share by Regions (2015-2020)
Table 11. Global Bacterial Pneumonia Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Bacterial Pneumonia Therapeutics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Bacterial Pneumonia Therapeutics Market Growth Strategy
Table 17. Main Points Interviewed from Key Bacterial Pneumonia Therapeutics Players
Table 18. Global Bacterial Pneumonia Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Bacterial Pneumonia Therapeutics Market Share by Players (2015-2020)
Table 20. Global Top Bacterial Pneumonia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacterial Pneumonia Therapeutics as of 2019)
Table 21. Global Bacterial Pneumonia Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Bacterial Pneumonia Therapeutics Product Solution and Service
Table 24. Date of Enter into Bacterial Pneumonia Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Bacterial Pneumonia Therapeutics Market Size Share by Type (2015-2020)
Table 28. Global Bacterial Pneumonia Therapeutics Revenue Market Share by Type (2021-2026)
Table 29. Global Bacterial Pneumonia Therapeutics Market Size Share by Application (2015-2020)
Table 30. Global Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Bacterial Pneumonia Therapeutics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Bacterial Pneumonia Therapeutics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Bacterial Pneumonia Therapeutics Market Share (2019-2020)
Table 34. North America Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Bacterial Pneumonia Therapeutics Market Share by Type (2015-2020)
Table 36. North America Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Bacterial Pneumonia Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Key Players Bacterial Pneumonia Therapeutics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Bacterial Pneumonia Therapeutics Market Share (2019-2020)
Table 40. Europe Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Bacterial Pneumonia Therapeutics Market Share by Type (2015-2020)
Table 42. Europe Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Bacterial Pneumonia Therapeutics Market Share by Application (2015-2020)
Table 44. China Key Players Bacterial Pneumonia Therapeutics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Bacterial Pneumonia Therapeutics Market Share (2019-2020)
Table 46. China Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. China Bacterial Pneumonia Therapeutics Market Share by Type (2015-2020)
Table 48. China Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. China Bacterial Pneumonia Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Key Players Bacterial Pneumonia Therapeutics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Bacterial Pneumonia Therapeutics Market Share (2019-2020)
Table 52. Japan Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Bacterial Pneumonia Therapeutics Market Share by Type (2015-2020)
Table 54. Japan Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Bacterial Pneumonia Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Bacterial Pneumonia Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Bacterial Pneumonia Therapeutics Market Share (2019-2020)
Table 58. Southeast Asia Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Bacterial Pneumonia Therapeutics Market Share by Type (2015-2020)
Table 60. Southeast Asia Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Bacterial Pneumonia Therapeutics Market Share by Application (2015-2020)
Table 62. India Key Players Bacterial Pneumonia Therapeutics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Bacterial Pneumonia Therapeutics Market Share (2019-2020)
Table 64. India Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. India Bacterial Pneumonia Therapeutics Market Share by Type (2015-2020)
Table 66. India Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. India Bacterial Pneumonia Therapeutics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Bacterial Pneumonia Therapeutics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Bacterial Pneumonia Therapeutics Market Share (2019-2020)
Table 70. Central & South America Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Bacterial Pneumonia Therapeutics Market Share by Type (2015-2020)
Table 72. Central & South America Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Bacterial Pneumonia Therapeutics Market Share by Application (2015-2020)
Table 74. AstraZeneca Company Details
Table 75. AstraZeneca Business Overview
Table 76. AstraZeneca Product
Table 77. AstraZeneca Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020) (Million US$)
Table 78. AstraZeneca Recent Development
Table 79. Nabriva Therapeutics Company Details
Table 80. Nabriva Therapeutics Business Overview
Table 81. Nabriva Therapeutics Product
Table 82. Nabriva Therapeutics Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020) (Million US$)
Table 83. Nabriva Therapeutics Recent Development
Table 84. SetLance Company Details
Table 85. SetLance Business Overview
Table 86. SetLance Product
Table 87. SetLance Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020) (Million US$)
Table 88. SetLance Recent Development
Table 89. Merck Company Details
Table 90. Merck Business Overview
Table 91. Merck Product
Table 92. Merck Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020) (Million US$)
Table 93. Merck Recent Development
Table 94. Daiichi Sankyo Company Company Details
Table 95. Daiichi Sankyo Company Business Overview
Table 96. Daiichi Sankyo Company Product
Table 97. Daiichi Sankyo Company Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020) (Million US$)
Table 98. Daiichi Sankyo Company Recent Development
Table 99. GlaxoSmithKline Company Details
Table 100. GlaxoSmithKline Business Overview
Table 101. GlaxoSmithKline Product
Table 102. GlaxoSmithKline Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020) (Million US$)
Table 103. GlaxoSmithKline Recent Development
Table 104. Pfizer Company Details
Table 105. Pfizer Business Overview
Table 106. Pfizer Product
Table 107. Pfizer Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020) (Million US$)
Table 108. Pfizer Recent Development
Table 109. Sanofi Pasteur Business Overview
Table 110. Sanofi Pasteur Product
Table 111. Sanofi Pasteur Company Details
Table 112. Sanofi Pasteur Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020) (Million US$)
Table 113. Sanofi Pasteur Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bacterial Pneumonia Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Antibiotics Features
Figure 3. Vaccines Features
Figure 4. Global Bacterial Pneumonia Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Mail Order Pharmacies Case Studies
Figure 8. Bacterial Pneumonia Therapeutics Report Years Considered
Figure 9. Global Bacterial Pneumonia Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Bacterial Pneumonia Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global Bacterial Pneumonia Therapeutics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Bacterial Pneumonia Therapeutics Market Share by Players in 2019
Figure 14. Global Top Bacterial Pneumonia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacterial Pneumonia Therapeutics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Bacterial Pneumonia Therapeutics Revenue in 2019
Figure 16. North America Bacterial Pneumonia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Bacterial Pneumonia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Bacterial Pneumonia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Bacterial Pneumonia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Bacterial Pneumonia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Bacterial Pneumonia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Bacterial Pneumonia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
肺炎治療薬の世界市場（～2026年） Pneumonia is a respiratory disease characterized by inflammation of air sacs in lungs due to bacterial or viral infection. The emergence of advanced diagnostic techniques to be one of the primary factors fueling the growth of the pneumonia therapeutics market in the coming years. Market Analysis and…- 細菌ワクチンの世界市場（～2026年） Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Different types of bacterial vaccines include, capsular polysaccharide vaccines, toxoid vaccines, purified protein vaccines, live attenuated bacterial vaccines, and killed bacterial vaccines. Rise in prevalence…
- 市中肺炎（CAP）の世界市場（～2026年） Community-acquired pneumonia (CAP) refers to pneumonia (any of several lung diseases) contracted by a person with little contact with the healthcare system. The market of CAP treatment and diagnosis in further segmented with respect to major geographies of North America, Europe, Asia-Pacific, and La…
- 人工呼吸器関連肺炎（VAP）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ventilator Associated Pneumonia (VAP) Therapeutics Market The global Ventilator Associated Pneumonia (VAP) Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ventilator As…
- 院内肺炎予防の世界市場（～2026年） HAP is defined as a lower respiratory infection, which does not incubate at the time of hospital admission but presents clinically 2 or more days after hospitalization.Incidence of HAP is more prevalent in the medical and surgical Intensive Care Units, and results in additional cost to the healthcar…